Sermorelin: costs, evidence and access
Heads up: Peptide Clarity Guide works with partners, and a few buttons below pay us if you join (you pay the same). Who pays plays no part in the order here, or in what we write. How we earn.
The short answer
Sermorelin is a GHRH fragment that stimulates pituitary growth-hormone release. Current compounded preparations are not FDA-approved. Adult findings differ by population and regimen: hormone responses and some secondary body-composition changes do not establish general wellness or athletic benefit. Compare the exact formulation, quantity, renewal interval, required care and full charge.
Definition
Sermorelin is a lab-made peptide matching the first 29 amino acids of growth hormone-releasing hormone (GHRH). It signals the pituitary to release your own growth hormone rather than supplying growth hormone itself.
Key facts
| Fact | Detail |
|---|---|
| Class | GHRH analog (first 29 amino acids of the natural hormone) |
| US status | Current compounded preparations are not FDA-approved. Former Geref approvals were withdrawn at the maker’s request; FDA later found the withdrawals were not for safety or effectiveness. The 503B Category 1 record is conditional evaluation[3] |
| Forms sold online | Injection, sublingual lozenge or tablet, orally dissolving tablet (ODT), nasal spray |
| Typical cost | Selected current offers below; quantities, forms and commitments differ |
| Who prescribes | A licensed clinician, usually by telehealth. Some programs ask for labs such as IGF-1. |
| Insurance | The cited commercial offers are self-pay; ask your insurer about the exact prescription |
Start with the exact offer and billing unit, then assess the population-specific evidence. A hormone increase is different from a clinical result. The prescription guide and provider checklist explain what to confirm before payment.
Sermorelin signals your pituitary, it doesn't replace growth hormone
Sermorelin is a compounded peptide that tells the pituitary to release growth hormone, instead of replacing growth hormone itself. Your body's own feedback still applies.
That's the main difference from prescription growth hormone, which is a separate, tightly labeled drug. With sermorelin, the pituitary does the work, so how much it responds varies from person to person.
Which goals sermorelin fits: what the studies show
Adult evidence is small and population-specific. A healthy-older-men study found no body-composition change, while a small Geref trial in HIV-associated lipodystrophy found secondary DXA changes. Modified analogs are separate molecules.
| Study / preparation | Population and design | Findings | Limits / read more |
|---|---|---|---|
| Vittone 1997, GHRH(1–29) [7] | 11 healthy older men; six weeks, before/after without a control arm | Nocturnal GH increased; no significant IGF-I or DXA body-composition change. Two of six strength tests and abdominal endurance improved. | Small uncontrolled study; muscle evidence |
| Corpas 1992, GHRH(1–29) [16] | 10 older men studied with 14-day regimens; nine young men provided baseline comparison | GH and IGF-I increased at the higher studied regimen | Hormone changes, not demonstrated long-term wellness benefit |
| Koutkia 2004, Geref [1] | 31 men with HIV-associated lipodystrophy; 12-week randomized study | IGF-I was the primary outcome. Secondary DXA lean-mass and trunk-fat differences; no total-fat change and no significant between-group visceral-fat difference | Not healthy-athlete evidence; population and endpoint detail |
| Thorner 1996, GHRH(1–29) [6] | 110 children treated; 86 eligible for efficacy analysis; open-label follow-up | Annualized height velocity increased from 1.6 to 3.1 in/year (4.1 to 8.0 cm/year) at six months | Not an adult outcome and not height gained over only six months |
| Khorram 1997, modified Nle27 analog [2] | 19 older adults; four-week placebo phase followed by 16 active weeks | Lean mass, insulin sensitivity, libido and well-being improved in men only; sleep unchanged; transient hyperlipidemia | Modified analog, not identical sermorelin; no parallel placebo treatment arm |
| Kern 1993 and Perras 1999 GHRH sleep protocols [17] [18] | IV crossover in 10 men; separate intranasal crossover in 12 young and 11 older men | IV study found no sleep change; nasal study reported altered REM/SWS with protocol-specific endocrine changes | Does not establish a reliable benefit from a commercial sermorelin spray or tablet |
These studies cannot be pooled as one interchangeable product or regimen. A primary hormone endpoint, secondary DXA finding and sleep-stage observation answer different clinical questions.
Read the table as a gap. A hormone rising is the step before a result. In the six-week healthy-older-men study, body composition did not change [7]. If muscle or fat loss is the goal, that's worth knowing before you start paying monthly. The body-composition shortlist shows what else people compare.
Koutkia tested Geref in 31 men with HIV-associated lipodystrophy for 12 weeks. Secondary DXA findings included increased lean mass and reduced trunk fat, with no total-fat change. These do not establish healthy-adult wellness benefits [1].
The separate Nle27 analog study reported increased lean mass in men only, unchanged sleep quality and transient hyperlipidemia. A modified analog is not identical sermorelin; tesamorelin is also a different drug [2].
What sermorelin costs: it depends mostly on the form
The selected offers below differ in formulation, quantity and commitment. They are not an exhaustive market range, and comparing service prices does not establish that an oral, nasal or injected product has equivalent clinical effects.
| Provider | Form | Published unit | Commitment / renewal | Included / confirm |
|---|---|---|---|---|
| Strut Health [9] | Lozenge | $99 per 30-lozenge 30-day supply | Selected 30-day auto-refill; separate 90-day option needs its own quote | Consultations, follow-ups and shipping |
| Strut Health [10] | Injection | $119 per 30-day vial | Selected 30-day auto-refill; separate 90-day option needs its own quote | Consultations, follow-ups and shipping |
| Brightmeds [11] | Injection | $129 monthly | Monthly renewal on cited offer | Medication, evaluation, follow-up and shipping; no separate membership |
| HealthRX [12] | Injection | $179 one-month plan | Longer plans have lower monthly equivalents | Medication, kit, provider visit, follow-up messages and shipping |
| AgelessRx [14] | Nasal spray | $149 first month; $199 afterward | Monthly subscription | Provider plan, messaging and shipping |
Also offered by (no standing monthly price published): AgelessRx (injection), Gala Partner. These selected offers are not an exhaustive market minimum or an efficacy ranking. Vial and lozenge quantities differ. Gala pairs a monthly starting label with a 28-day supply; the actual renewal charge dates require confirmation. State access and testing must be confirmed for the exact prescription.
An introductory price can require a larger payment up front. Confirm the amount charged today, the later recurring charge and the actual interval. The cost guide keeps these distinctions alongside exact primary product sources.
Month to month or prepaid: what plan length does to the price
Some cited programs advertise lower monthly equivalents on longer plans. That increases the commitment and can change refund eligibility; do not infer the full bill or renewal price from a headline alone.
| Offer | Commitment distinction | Confirm |
|---|---|---|
| HealthRX [12] | One-month subscription versus longer prepaid plans | Total charged today and unused-treatment refunds |
| AgelessRx [13] | Introductory injection offer requires a three-month payment | Exact campaign, later charge and renewal period |
| Gala [15] | A 28-day offer and separate 12-month advertised equivalent | Total prepaid charge, renewal dates and refund terms |
An advertised monthly equivalent on a longer plan is not a stand-alone monthly subscription.
Read the exact cancellation deadline and what happens after a pharmacy receives an order. Strut’s terms distinguish30- and90-day charges, while AgelessRx’s main injection offer requires a prepaid introduction. Cancellation of a future subscription is not necessarily a refund of an existing order [10] [13].
Before choosing any commitment, discuss whether treatment is appropriate, what monitoring is required and which clinical outcome would justify continuing. A less expensive plan does not establish a benefit.
What to check on any sermorelin program before you pay
Four things separate programs more than their headline price. You can check all of them before you enter a card.
- The month-two price. Intro offers are common. Ask what you pay from the second month on the plan you're picking.
- The pharmacy. Request the facility dispensing your exact preparation, verify its license and ask which compounding framework applies.
- Labs. Whether IGF-1 or other labs are required, and whether they're in the price.
- Membership fees. A few programs add one on top of the medication, which changes the real monthly total.
How to get a prescription: intake, a clinician, a pharmacy
You need a prescription from a licensed clinician. Online programs run an intake, a clinician review and, at some, labs such as IGF-1, then a compounding pharmacy ships it.
Expect questions about your health history and goals. Programs differ on labs: some require them, some leave it to the clinician. States vary too, so check yours at signup. The step-by-step, including what to ask before you pay, is in how to get sermorelin.
How long it takes: hormone changes come in weeks
Corpas observed hormone changes during 14-day GHRH(1–29) regimens. In the modified Nle27 analog study, IGF-I increased within two weeks and later moved back toward baseline. Neither observation establishes when a person using a different commercial product will feel a benefit [16] [2].
So be wary of any program that promises visible results by a date. What the studies timed, and what they didn't, is in how long sermorelin takes to work.
Formulation and route matter to the evidence
The selected commercial offers include injections, lozenges or dissolving tablets, and nasal sprays. Evidence from one studied preparation cannot be transferred to another route without applicable data. Research nasal protocols exist; that is different from validating a particular retail spray.
- Injection. Several GHRH(1–29) studies used subcutaneous preparations, with differing populations and regimens [7] [1].
- Lozenge or dissolving tablet. A published injection result does not establish absorption or clinical effect from the commercial oral preparation.
- Nasal spray. Intranasal GHRH research measured sleep and endocrine outcomes. The exact formulation and protocol matter; it does not establish equivalence to commercial sprays [18].
Ask for data on the exact formulation and clinical endpoint. A proposed delivery mechanism, a prescription and a drug concentration do not by themselves establish equivalent absorption, exposure or benefit.
Why it's compounded, not FDA-approved
Geref had historical diagnostic and pediatric-treatment approvals. FDA withdrew the approvals at the maker’s request, effective in 2009, and in 2013 determined the products were not withdrawn for safety or effectiveness. That historical decision does not approve the compounded product offered today [3] [4].
| Date | What happened | What it means for you |
|---|---|---|
| December 28, 1990 | Geref Diagnostic approved to test the pituitary's growth hormone response [3] | Sermorelin's first FDA approval |
| September 26, 1997 | Geref approved for growth hormone deficiency in children with growth failure [3] | The treatment approval |
| 2008 | The maker tells FDA it's discontinuing both Geref products [3] | The maker discontinues the cited Geref products |
| May 19, 2009 | FDA withdraws both approvals at the maker's request, effective June 18, 2009 [4] | Those Geref approvals are withdrawn |
| March 4, 2013 | FDA determines Geref wasn't withdrawn for safety or effectiveness reasons [3] | The door stays open to generic approval |
| March 21, 2025 | FDA's list for outsourcing facilities shows sermorelin acetate in Category 1, under evaluation [5] | Conditional interim evaluation; not finished-product approval |
FDA’s 503B Category 1 nomination record concerns outsourcing facilities and a conditional interim policy. It does not automatically authorize every pharmacy, formulation or route. Traditional 503A compounding has separate ingredient and patient-specific requirements; absence from a nominations category alone does not resolve every legal criterion. Current compounded preparations do not undergo FDA premarket approval for safety, effectiveness and quality [5] [19].
Sermorelin with other treatments
People often ask about pairing sermorelin with something else. Each pair has its own page. Here's the one-line answer for each.
- Ipamorelin. Adding sermorelin does not establish authorization, safety or efficacy for another ingredient. See the combination guide.
- Tirzepatide. Separate product indications do not establish combination benefit or safety. See sermorelin and tirzepatide.
- NAD+. A shared catalog does not establish safe or effective co-use. Read the NAD+ evidence.
- Injectable GHK-Cu. Every ingredient and route needs its own assessment; a blend does not transfer topical nomination status to an injection. See injectable GHK-Cu.
Sermorelin or TRT? Two different hormones
Sermorelin works on growth hormone. TRT replaces testosterone. They aren't substitutes, though people weigh them for the same goals: energy, body composition and feeling like themselves.
Testosterone products have their own indications, formulations and regulatory status. Neither a testosterone label nor the former Geref history makes the two treatments interchangeable. Read sermorelin and testosterone for the distinct questions to bring to a clinician.
Who sermorelin isn't for
A current compounded preparation has no FDA-reviewed product label establishing its own safety profile. Historical labels and short studies cannot establish long-term safety of every commercial adult regimen.
Discuss your medical history, medicines, relevant contraindications and required monitoring with the clinician. Ask how symptoms or adverse effects will be assessed and when a treatment would be stopped. A general website intake description does not establish that your risks have been evaluated.
Still deciding? Start the quiz, or compare programs on the body-composition shortlist.
Research on Sermorelin
How to check a peptide provider before you pay
A polished checkout is easy to assess. The clinician, pharmacy and exact prescription behind it deserve a closer look.
Does sermorelin build muscle? Small studies, mixed findings
More growth hormone sounds like more muscle. Small studies differ by population and protocol; lean-mass changes do not establish athletic benefit.
Sermorelin for weight loss: the evidence is thin
Sermorelin gets marketed as a fat burner. Here's what the studies in adults actually measured, where the belly-fat claims really come from, and what's approved for weight.
Sermorelin and testosterone: different hormones, different jobs
Sermorelin often gets sold next to testosterone, and sometimes as a stand-in for it. Here's what it actually raises, what the studies measured, and where testosterone treatment fits.
How to get sermorelin: prescription, programs, and what to avoid
A prescription, a clinician and a pharmacy. Here's how the steps work online, and which programs offer it.
Sermorelin with tirzepatide: what's known, and what to ask first
People ask about this to protect muscle on a GLP-1. Here's what the labels and studies actually say.
Sermorelin cost: what telehealth programs charge each month
Compare the exact supply, renewal terms and commitment. A cheaper lozenge or prepaid plan does not establish equivalent clinical benefit.
How long sermorelin takes to work, and what "working" means
Growth hormone moves first. Whether you feel different is a separate question, and the adult studies are small.
Compare providers
Shortlists for this treatment, In first, with each provider's monthly price.
Providers that offer Sermorelin
- Read the review →
AgelessRx
People comparing several prescriptions who can check each formulation, renewal and care plan.
- Read the review →
Arc-1
Not a pick yet: it sells monthly subscriptions but prints no terms for canceling one.
- Read the review →
BioGlow Health
People who will confirm the exact quantity, refill schedule, clinician and pharmacy before paying.
- Read the review →
bmiMD
People prepared to obtain a written payment schedule and keep portal cancellation confirmation.
- Read the review →
Bodybuilding Health+
Lifters who want NAD+ or sermorelin on a simple monthly plan and don't mind calling a pharmacy.
- Read the review →
Brightmeds
People who want a simple month-to-month price for NAD+ or sermorelin without joining a membership.
- Read the review →
DirectMeds
People who will obtain the exact product, renewal schedule and pharmacy assignment before paying.
- Read the review →
EdgeRx
Men in midlife who want needle-free longevity peptides on a cancel-anytime monthly plan.
- Read the review →
ElitePhysiqMD
People who will clarify the exact product, purchase path and pharmacy before considering a commitment.
- Read the review →
ElleS
People who will confirm their exact plan total, pharmacy and clinical-refusal fees before payment.
- Read the review →
Embody
People who can confirm the full bundle and accept limited voluntary refund rights.
- Read the review →
Fridays
People comparing several programs who will confirm the exact commitment and total before enrollment.
- Read the review →Visit site →
GalaPartner
People who want weight, menopause or longevity care in one app and can commit to a longer plan.
- Read the review →
Goldspan Health
People comparing a broad catalog who will confirm laboratory costs and the dispensing facility.
- Read the review →
HealthRX
People comparing several products who will distinguish introductory payments, prepaid terms and renewal costs.
- Read the review →
KIN Meds
People who will confirm the exact supply, total payment and whether their selected program renews.
- Read the review →
Lttl
People comparing treatment and commitment options who can obtain a binding charge schedule first.
- Read the review →
Luvo Health
People comparing specified four-week offers who will check the earliest processing date and refund limits.
- Read the review →
MangoRx
People who will distinguish testing from ongoing medication and clarify the actual refill agreement.
- Read the review →
Next Vial
People comparing several prescription options who can obtain selected terms before payment.
- Read the review →
Nova
Texas or Florida residents willing to confirm the complete invoice and clinical-review refund terms before paying.
- Read the review →
Oak
People comparing NAD+ service terms who will clarify the exact formulation before paying.
- Read the review →
PauseRx
People who want to approve each month's refill instead of being charged automatically.
- Read the review →
PeterMD
People who will confirm the actual pharmacy identity, current authorization and selected payment schedule.
- Read the review →
Precision Telemed
People comparing a full treatment program with its maintenance, testing and prepaid alternatives.
- Read the review →
Prime Doctor RX
People who want several longevity treatments reviewed together instead of in separate visits.
- Read the review →
RNK Health
People willing to resolve the complete invoice and pharmacy assignment before choosing a monthly or prepaid plan.
- Read the review →
Science & Co
Readers prepared to confirm the exact prepaid amount, renewal interval and pharmacy before choosing.
- Read the review →
SkinnyRx
People who can obtain the complete renewal quote and compare cancellation, refund and guarantee conditions.
- Read the review →Visit site →
Strut HealthPartner
People who want one refill charge covering the visit, follow-ups and shipping.
- Read the review →
System Labs
People who will obtain a written current price, renewal interval and assigned pharmacy before ordering.
- Read the review →
TeleZen MD
People comfortable confirming the complete payment and the strict order-stage cancellation conditions.
- Read the review →
Wellorithm
Buyers willing to resolve the renewal schedule and pharmacy details before paying.
- Read the review →
WePeptideRx
People who will confirm their selected formulation, current charge and renewal schedule before checkout.
Frequently asked
- How much does sermorelin cost?
- Compare the selected offers above by quantity, formulation and charge interval. Strut’s selected lozenge and injection quotes cover 30-day supplies, while other offers use calendar-month subscriptions or prepaid introductions. The table is not an exhaustive market minimum.
- Does sermorelin help hair growth?
- No applicable controlled evidence establishing hair-growth benefit from the cited commercial preparations was identified. Hormone changes do not establish a hair-loss treatment effect.
- Does sermorelin give you energy?
- The cited GHRH and modified-analog studies do not establish a dependable energy benefit from a current commercial regimen. Some modified-analog well-being outcomes were measured; that is not equivalent product evidence.
- What is sermorelin GHK?
- It is a marketed combination name. Adding sermorelin does not establish authorization or safety for injectable GHK-Cu. Assess every ingredient, preparation and route separately.
- Can you take sermorelin with retatrutide?
- Retatrutide remains investigational and FDA says it cannot be used in compounding under federal law. Authorized research is a separate framework; a commercial combination’s benefit and safety are not established.
- Do you need a prescription for sermorelin?
- The cited compounded offers require clinician assessment and a prescription, alongside applicable pharmacy and product requirements. A retail research-use label or trial listing alone does not authorize treatment of people.
Sources
- [1] Koutkia P. Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial (2004). PMID 15249570
- [2] Khorram O. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women (1997). PMID 9141536
- [3] Determination That GEREF (Sermorelin Acetate) Injection… Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness (Federal Register, March 4, 2013) (2013). FDA
- [4] Novartis Pharmaceuticals Corp. et al.; Withdrawal of Approval of 92 New Drug Applications and 49 Abbreviated New Drug Applications (Federal Register, May 19, 2009) (2009). FDA
- [5] Bulk Drug Substances Nominated for Use in Compounding Under Section 503B (updated March 21, 2025) (2025). FDA
- [6] Thorner M. Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group (1996). PMID 8772599
- [7] Vittone J. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men (1997). PMID 9005976
- [8] Khorram O. Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women (1997). PMID 9360512
- [9] Strut Health oral sermorelin supply and pricing (2026). Company website
- [10] Strut Health injectable sermorelin supply and pricing (2026). Company website
- [11] Brightmeds sermorelin monthly offer and inclusions (2026). Company website
- [12] HealthRX sermorelin plans and inclusions (2026). Company website
- [13] AgelessRx sermorelin injection prepaid introductory offer (2026). Company website
- [14] AgelessRx sermorelin nasal introductory and recurring prices (2026). Company website
- [15] Gala sermorelin supply and longer-plan information (2026). Company website
- [16] Corpas E. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men (1992). PMID 1379256
- [17] Kern W. Systemic growth hormone does not affect human sleep (1993). PMID 8501147
- [18] Perras B. Sleep and endocrine changes after intranasal administration of growth hormone-releasing hormone in young and aged humans (1999). PMID 10451909
- [19] FDA: understanding the risks of compounded drugs (2026). FDA
- [20] FDA Investigational New Drug application framework (2026). FDA
- [21] FDA concerns about unapproved GLP-1 drugs, including retatrutide (2026). FDA